Abstract
This work aims to study the function of curculigoside in osteoporosis and explore whether DNMT1 is closely involved in osteoblast activity. After OB-6 osteoblasts were treated with hydrogen peroxide (H2O2), a curculigoside treatment group was set up and a series of biological tests including MTT, flow cytometry, western blotting, ROS fluorescence intensity, mitochondrial membrane potential, and ELISA experiments were performed to verify the effect of curculigoside on the activity of osteoblasts. Then, alkaline phosphatase (ALP) activity, alizarin red staining, PCR, and western blotting assays were performed to detect the effects of curculigoside on osteoblast function. By constructing DNMT1 knockdown and overexpression OB-6 cell lines, the effect of DNMT1 on osteoblast function was verified. In addition, the expression level of Nrf2 in each group was detected to speculate the mechanism of DNMT1 in osteoporosis. The cell activity and level of bcl-2 and SOD were significantly increased; the cell apoptosis, ROS fluorescence intensity, mitochondrial membrane potential, MDA and level of caspase-3, Bax, and CAT was reduced in curculigoside treatment group compared with H2O2-induced OB-6 osteoblasts. Meanwhile, the ALP activity, number and area of bone mineralized nodules, and gene and protein expression of OSX and OPG were significantly elevated in curculigoside group. Moreover, DNMT1 knockdown had a similar promotion effect on osteoblast function as curculigoside, and DNMT1 overexpression could reverse the promotion effect of curculigoside on osteoblast function. Further mechanistic studies speculated that DNMT1 might play a role in osteoporosis by affecting Nrf2 methylation. Curculigoside enhances osteoblast activity through DNMT1 controls of Nrf2 methylation.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The skeleton is the hard organ that makes up the vertebrate endoskeleton and has functions such as movement, support, and protection of the body. The thickness of human bones is genetically determined and influenced by lifestyle. The degeneration of bones affects the function of the whole body (Cymet et al. 2000). Old age, trauma, braking, and viscera dysfunction and other factors result in bone thinning atrophy, known as osteoporosis (Gosset et al. 2021). The danger of fractures caused by osteoporosis is enormous and is one of the main causes of disability and death in elderly patients (Alexiou et al. 2018; Lai et al. 2022). The study of the occurrence, development, and pathological characteristics of osteoporosis is important for finding more effective treatments for osteoporosis.
Osteoporosis is a common clinical category of orthopedic diseases, and calcium deficiency is only the surface cause of osteoporosis; the most important cause is the change of bone mechanism in the body (Fang et al. 2022). The human skeleton undergoes a dynamic process of change at all times, as old bone is continuously absorbed and degraded by osteoclasts, while new bone is remodeled by osteoblasts derived from bone marrow mesenchymal stem cells (McDonald et al. 2021; Fischer and Haffner-Luntzer 2022). The pathological basis for the development of osteoporosis is the disruption of the balance of bone reconstruction due to the imbalance of osteoclast and osteoblast activities (Chen et al. 2022). Since the functional decline of osteoblasts is an important cause of the imbalance of bone metabolism and bone loss, improving the bone-forming capacity of osteoblasts has direct implications for the prevention and treatment of osteoporosis.
Curculigo orchioides is a perennial herb in the Lithospermum family, and its medicinal part is the rhizome (Valls et al. 2006). It is rich in chemical components, such as phenols, phenolic glycosides, and lignans (Zuo et al. 2010). Among them, curculigoside is the main active component of curculigo orchioides (Zuo et al. 2010). Curculigoside is a benzoate derivative with a molecular formula of C22H26O11 and a molecular weight of 466.44. Research shown that curculigoside can improve learning and memory and has anti-inflammatory, antioxidant, immune enhancement, protection against ischemia/reperfusion injury, and other pharmacological effects (Han et al. 2020; Liu et al. 2021). Moreover, Zhao et al. 2015 found that curculigoside can increase bone density and serum SOD and CAT levels in ovariectomized rats with osteoporosis (Zhao et al. 2015). Thus, we conducted a cell experiment to study the function of curculigoside in osteoporosis and explore the potential mechanism through OB-6 osteoblasts.
Materials and methods
Cell transfection and groups
OB-6 osteoblastic cells were obtained from the BFB (Shanghai, China) and cultured as described previously (Guo et al. 2017). Then, OB-6 osteoblastic cells were incubated with or without 300 µm H2O2 (Sigma-Aldrich, St Louis, MO) for 12 h or 10 µM curculigoside (curculigoside A, MCE, Sigma-Aldrich) for another 60 h (Zhang et al. 2019; Lian et al. 2021). For further mechanistic studies, OB-6 osteoblastic cells were transfected with DNMT1 siRNA (OBiO, Shanghai, China) or DNMT1 mimics through Lipofectamine™ 3000 transfection reagent (Invitrogen, Grand Island, NY). At 48 h after DNMT1 mimics transfection, the cells were treated with 10 μM curculigoside for another 60 h.
Cell viability assay
The MTT assay was used to study the cell viability. The MTT absorbance optical density (OD) at 570 nm was measured.
Cell apoptosis assay
After centrifugated and resuspended, cell suspension of different group was pipetted and incubated with Annexin V-PE/7-AAD. Then, the cell apoptosis was analyzed using a flow cytometry (Agilent Technologies, Santa Clara, CA).
Western blot
Cellular proteins were determined by bicinchoninic acid (BCA) kit (Thermo Fisher Scientific, Waltham, MA), resolved with SDS-PAGE electrophoresis (Beyotime Biotechnology Co., Ltd., Shanghai, China), and transferred to PVDF (Millipore, USA). Then, proteins were sealed with 5% skim milk and immunodetected with primary antibodies against caspase-3 (ab184787, 1:2000, Abcam, Cambridge, UK), Bax (ab32503, 1:10,000, Abcam), bcl-2 (ab182858, 1:2000, Abcam), osterix (OSX, ab209484, 1:1000, Abcam), osteoprotegerin (OPG, ab73400, 1:1000, Abcam), and GAPDH (60,004–1-Ig, 1:50,000, PTG). After incubated with peroxidase conjugate secondary antibody containing horseradish (ZB-2305, 1:10,000, ZSGB, China), protein bands were analyzed through Image Lab Software (Bio-Rad, Hercules, CA).
Cell ROS and mitochondrial membrane potential detection
The cells in each group were rinsed with PBS twice. After that, samples were processed and flow cytometry was performed according to the instructions of ROS detection kit (Nanjing Jiancheng Bioengineering Research Institute, Nanjing, China) and mitochondrial membrane potential detection kit (Elabscience Biotechnology Co.,Ltd, Wuhan, China), respectively.
Enzyme-linked immunosorbent assay
The activity of superoxide dismutase (SOD), malondialdehyde (MDA), and catalase (CAT) was detected through enzyme-linked immunosorbent assay (ELISA) kits (Nanjing Jiancheng Bioengineering Research Institute, Nanjing, China).
Alkaline phosphatase activity assay
Cells were lysed with 100 μL of western and IP cell lysate combined with 1% of 0.01 mol/L PMSF; the cell lysate was collected. The alkaline phosphatase (ALP) activity was expressed as p-nitrophenol (μmol/L) released per milligram of protein, and the ALP activity of the cells in the blank control group was expressed as 100%, and the ratio of ALP activity of the other treated groups to the ALP activity of the blank control group × 100%. One hundred percent indicates the relative ALP activity of each group of cells after treatment.
Alizarin red staining
The formation of bone mineralization nodules in osteoblasts was observed by alizarin red staining. Cells were fixed for 10 min with precooled 10% neutral formaldehyde solution before staining. After 3 times of rinsing with PBS, the cells were incubated with 0.1% Tris–HCl alizarin red dye. Finally, the cells were rinsed with PBS until the floating color was removed, then dried and photographed.
QRT-PCR
Total RNA was extracted through TRIzon Reagent (Thermo Fisher Scientific, Waltham, MA) and reversed transcription into cDNA. Then, SYBR Green PCR Master Mix (Thermo Fisher Scientific) was used to perform real-time PCR. The relative expression of DNMT1, OSX, and OPG was calculated through 2−ΔΔCT method with GAPDH as normalizing control.
Immunofluorescence
Cells were fixed with 4% paraformaldehyde and treated with 0.1% TritonX-100. After being blocked with bovine serum albumin, cells were incubated with anti-Nrf2 antibody (16,396–1-AP, PTG) at 4°C overnight. After incubated with Alexa Fluor 488 coupled (Invitrogen), cells were observed under a fluorescence microscope.
Statistical methods
All experiments were repeated at least three times. GraphPad software was applied and p-value < 0.05 was considered statistically significant. All data were expressed as mean ± SD and analyzed by t-test between two groups and LSD test following ANOVA between multiple groups.
Results
Effect of curculigoside on osteoblast activity
The proliferation and apoptosis in OB-6 osteoblasts was analyzed using MTT (Fig. 1A), flow cytometry (Fig. 1B), and western blotting (Fig. 1C), and the results showed that the cell proliferation and bcl-2 protein expression were significantly increased and the cell apoptosis and expression of caspase-3 and Bax protein was markedly reduced in the curculigoside treatment group compared with the model group (p < 0.05, respectively). The findings suggested that curculigoside could promote proliferation and inhibit apoptosis of OB-6 osteoblasts co-treated with H2O2.
Effect of curculigoside on oxidative stress in OB-6 osteoblasts
Oxidative stress is a causative factor in osteoporosis (Kimball et al. 2021). Figure 2A–C reveal that compared with normal control group, the SOD level was observably decreased and the ROS fluorescence intensity, mitochondrial membrane potential, and level of MDA and CAT was markedly increased in model group (p < 0.05, respectively). However, curculigoside treatment could reversed those oxidative stress indexes in OB-6 osteoblasts. All these results suggested that curculigoside could ameliorate the oxidative damage induced by H2O2 in OB-6 osteoblasts.
Effect of curculigoside on the function of osteoblast
ALP activity (Fig. 3A), alizarin red staining (Fig. 3B), western blotting (Fig. 3C), and PCR (Fig. 3D) assays were performed to detect the effects of curculigoside on osteoblast function. Compared with the control group, the concentration of ALP, number and area of bone mineralized nodules, and protein and mRNA expression of OSX and OPG were markedly decreased in model group (p < 0.05, respectively). Moreover, the concentration of ALP, area of bone mineralized nodules, and protein and mRNA expression of OSX and OPG were significantly elevated in curculigoside group compared with that in model group (p < 0.05, respectively). All those findings indicated that curculigoside could improve the osteoblast function of OB-6 osteoblasts.
Effect of silencing DNMT1 on the function of osteoblasts
The level of DNMT1 in control, model, and curculigoside groups was detected and the results showed that the level of DNMT1 mRNA increased significantly in the model group than in the control group (p < 0.05, Fig. 4A). Therefore, DNMT1 knockdown OB-6 cell lines were established and the effect of DNMT1 on osteoblast function was verified. DNMT1 siRNA was found to cause a dramatical decrease of DNMT1 in OB-6 osteoblasts than that in sh-NC group (p < 0.05, Fig. 4A), which means that the mold is successful. Moreover, compared with the model group, the number and area of bone mineralized nodules and the expression of OSX and OPG were markedly increased, while the cell apoptosis and ROS fluorescence intensity were markedly reduced in DNMT1-KO group (p < 0.05, respectively, Fig. 4B–E). The results indicated that silencing DNMT1 could improve the osteoblast function of OB-6 osteoblasts.
Effect of DNMT1 overexpression on the function of osteoblasts
DNMT1 overexpression OB-6 cell lines were further established and DNMT1 mimics was found to cause a significantly increased of DNMT1 in OB-6 osteoblasts than that in NC group (p < 0.05, Fig. 5A). Meanwhile, compared with the curculigoside group, the gene expression of OSX and OPG was markedly decreased, and the cell apoptosis and ROS fluorescence intensity were markedly increased in curculigoside + DNMT1 mimics group (p < 0.05, respectively, Fig. 5A–C). The results suggested that DNMT1 overexpression could disrupt the enhancing effect of curculigoside on osteoblast function.
Curculigoside may enhance osteoblast activity through DNMT1 controls of Nrf2 methylation
To further speculate the mechanism of curculigoside in osteoporosis, the expression of Nrf2 in control, model, and curculigoside groups was studied. Compared with the control group, the gene (Fig. 6A), protein (Fig. 6B), and fluorescence intensity (Fig. 6C) of Nrf2 were markedly reduced in the model group (p < 0.05, respectively). Moreover, the gene, protein, and fluorescence intensity of Nrf2 were markedly increased in the curculigoside group (p < 0.05, respectively). Taken together, curculigoside may enhance osteoblast activity through DNMT1 controls of Nrf2 methylation.
Discussion
Osteoporosis is a multifactorial systemic bone metabolic disease characterized by a decrease in bone mass per unit volume and destruction of bone tissue microarchitecture (Alexiou et al. 2018; Lai et al. 2022). Almost all bones are at risk of fracture due to osteoporosis. Therefore, it is of great social value and significance to study the pathogenesis and pathological characteristics of osteoporosis in order to find more effective treatment methods.
The decreased osteogenic capacity and increased osteoclastic capacity of bone lead to a rate of bone resorption that exceeds the rate of bone formation (Chen et al. 2017). The disturbances and imbalances in bone metabolism is the fundamental causes of osteoporosis in middle-aged and elderly people (Chen et al. 2017). Therefore, promoting new bone formation to replace lost bone tissue is the key to the treatment of osteoporosis. In recent years, oxidative stress as a risk factor of osteoporosis has been paid more and more attention. Oxidative stress can promote the occurrence and development of osteoporosis (Agidigbi and Kim 2019; Torres et al. 2021). The overproduction of ROS that is not balanced by adequate levels of antioxidants can lead to oxidative stress, which in turn causes oxidative damage to cells (Daenen et al. 2019). At the same time, as the body ages, estrogen levels decline and ROS production increases, and excessive ROS inhibit bone formation by osteoblasts, leading to bone loss and osteoporosis (Lephart and Naftolin 2021). It has been found that curcuma zedoary saponins can reduce oxidative stress and osteoclast formation (Wang et al. 2010). In view of this, we investigated the role of curcumin in osteoporosis and demonstrated that curcumin alleviates osteoporosis by regulating osteoblast activity.
The DNMT1 gene uses information about DNA methylation patterns in the parent chain to methylate the daughter strand in freshly copied hemimethylated DNA (Svedružić ŽM 2011). DNMT1 can also regulate gene expression independent of its catalytic activity and is involved in multiple processes (Mohan 2022). The present study identified upregulated expression of DNMT1 in H2O2-induced OB-6 osteoblasts, suggesting that DNMT1 may be a functional gene in osteoporosis. Based on the transfected with DNMT1 siRNA or DNMT1 mimics, the results found that silencing DNMT1 improves the osteoblast function of OB-6 osteoblasts and DNMT1 overexpression disrupts the enhancing effect of curculigoside on osteoblast function. In addition, Nrf2 is a major regulator of oxidative stress and plays a key role in the pathogenesis of osteoporosis (Chen et al. 2021). As a key anti-osteoporotic factor, the hypermethylation of Nrf2 promoter caused by abnormal increase of DNMT may be the pathogenesis of osteoporosis (Chen et al. 2021). Consistent with previous study, we found that curculigoside may enhance osteoblast activity through the control of Nrf2 methylation by DNMT1.
Conclusions
In conclusion, we found that curculigoside has a protective effect against osteoporosis. In-depth studies revealed that curculigoside attenuates osteoporosis through regulating DNMT1-mediated osteoblast activity. These events, together with the fact that curculigoside modulates Nrf2 level and there is an interaction between DNMT1 and Nrf2, further speculated that curculigoside may enhance osteoblast activity through DNMT1 controls of Nrf2 methylation. These data are important for understanding the progression of osteoporosis and help explain the mechanisms by which curculigoside plays a protective role in osteoporosis. At the same time, it also provides an experimental basis for the use of curculigoside in the prevention and treatment of osteoporosis.
Data Availability
All data generated or analysed during this study are included in this published article.
References
Agidigbi TS, Kim C (2019) Reactive oxygen species in osteoclast differentiation and possible pharmaceutical targets of ROS-mediated osteoclast diseases. Int J Mol Sci 20:3576
Alexiou KI, Roushias A, Varitimidis SE, Malizos KN (2018) Quality of life and psychological consequences in elderly patients after a hip fracture: a review. Clin Interv Aging 13:143–150
Chen W, Wu P, Yu F, Luo G, Qing L, Tang J (2022) HIF-1α regulates bone homeostasis and angiogenesis, participating in the occurrence of bone metabolic diseases. Cells 11:3552
Chen X, Chen J, Xu D, Zhao S, Song H, Peng Y (2017) Effects of osteoglycin (OGN) on treating senile osteoporosis by regulating MSCs. BMC Musculoskelet Disord 18:423
Chen X, Zhu X, Wei A, Chen F, Gao Q, Lu K, Jiang Q, Cao W (2021) Nrf2 epigenetic derepression induced by running exercise protects against osteoporosis. Bone Res 9:15
Cymet TC, Wood B, Orbach N (2000) Osteoporosis. J Am Osteopath Assoc 100:S9-15
Daenen K, Andries A, Mekahli D, Van Schepdael A, Jouret F, Bammens B (2019) Oxidative stress in chronic kidney disease. Pediatr Nephrol 34:975–991
Fang H, Deng Z, Liu J, Chen S, Deng Z, Li W (2022) The mechanism of bone remodeling after bone aging. Clin Interv Aging 17:405–415
Fischer V, Haffner-Luntzer M (2022) Interaction between bone and immune cells: implications for postmenopausal osteoporosis. Semin Cell Dev Biol 123:14–21
Guo S, Chen C, Ji F, Mao L, Xie Y (2017) PP2A catalytic subunit silence by microRNA-429 activates AMPK and protects osteoblastic cells from dexamethasone. Biochem Biophys Res Commun 487:660–665
Gosset A, Pouillès JM, Trémollieres F (2021) Menopausal hormone therapy for the management of osteoporosis. Best Pract Res Clin Endocrinol Metab 35:101551
Han J, Wan M, Ma Z, Hu C, Yi H (2020) Prediction of targets of curculigoside A in osteoporosis and rheumatoid arthritis using network pharmacology and experimental verification. Drug Des Devel Ther 14:5235–5250
Kimball JS, Johnson JP, Carlson DA (2021) Oxidative stress and osteoporosis. J Bone Joint Surg Am 103:1451–1461
Lai EC, Lin TC, Lange JL, Chen L, Wong ICK, Sing CW, Cheung CL, Shao SC, Yang YK (2022) Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study. Osteoporos Int 33:1155–1164
Lephart ED, Naftolin F (2021) Menopause and the skin: old favorites and new innovations in cosmeceuticals for estrogen-deficient skin. Dermatol Ther (heidelb) 11:53–69
Lian WS, Wu RW, Chen YS, Ko JY, Wang SY, Jahr H, Wang FS (2021) MicroRNA-29a mitigates osteoblast senescence and counteracts bone loss through oxidation resistance-1 control of FoxO3 methylation. Antioxidants (Basel) 10:1248
Liu M, Liu S, Zhang Q, Fang Y, Yu Y, Zhu L, Liu Y, Gong W, Zhao L, Qin L, Zhang Q (2021) Curculigoside attenuates oxidative stress and osteoclastogenesis via modulating Nrf2/NF-κB signaling pathway in RAW264.7 cells. J Ethnopharmacol 275:114129
McDonald MM, Kim AS, Mulholland BS, Rauner M (2021) New insights into osteoclast biology. JBMR plus 5:e10539
Mohan KN (2022) DNMT1: catalytic and non-catalytic roles in different biological processes. Epigenomics 14:629–643
Svedružić ŽM (2011) Dnmt1 structure and function. Prog Mol Biol Transl Sci 101:221–254
Torres ML, Wanionok NE, McCarthy AD, Morel GR, Fernández JM (2021) Systemic oxidative stress in old rats is associated with both osteoporosis and cognitive impairment. Exp Gerontol 156:111596
Valls J, Richard T, Larronde F, Leblais V, Muller B, Delaunay JC, Monti JP, Ramawat KG, Mérillon JM (2006) Two new benzylbenzoate glucosides from Curculigo orchioides. Fitoterapia 77:416–419
Wang YK, Hong YJ, Wei M, Wu Y, Huang ZQ, Chen RZ, Chen HZ (2010) Curculigoside attenuates human umbilical vein endothelial cell injury induced by H2O2. J Ethnopharmacol 132:233–239
Zhang Q, Zhao L, Shen Y, He Y, Cheng G, Yin M, Zhang Q, Qin L (2019) Curculigoside protects against excess-iron-induced bone loss by attenuating Akt-FoxO1-dependent oxidative damage to mice and osteoblastic MC3T3-E1 cells. Oxid Med Cell Longev 2019:9281481
Zhao L, Liu S, Wang Y, Zhang Q, Zhao W, Wang Z, Yin M (2015) Effects of curculigoside on memory impairment and bone loss via anti-oxidative character in APP/PS1 mutated transgenic mice. PLoS ONE 10:e0133289
Zuo AX, Shen Y, Jiang ZY, Zhang XM, Zhou J, Lü J, Chen JJ (2010) Three new phenolic glycosides from Curculigo orchioides G. Fitoterapia 81:910–913
Acknowledgements
Not applicable.
Funding
This work is supported by Postdoctoral Program of Shandong University of Traditional Chinese Medicine and Hospital-level Research Project of Rizhao Hospital of Traditional Chinese Medicine (No. RZZY2023JC01).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wang, M., Cui, K., Guo, J. et al. Curculigoside attenuates osteoporosis through regulating DNMT1 mediated osteoblast activity. In Vitro Cell.Dev.Biol.-Animal 59, 649–657 (2023). https://doi.org/10.1007/s11626-023-00813-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-023-00813-y